The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington’s Disease
Sign Up to like & getrecommendations! Published in 2025 at "CNS Drugs"
DOI: 10.1007/s40263-025-01171-x
Abstract: Huntington’s disease (HD) is a rare, fatal, chronic progressive neurodegenerative disorder with a significant unmet medical need for effective treatments. Pridopidine is a novel, first-in-class, highly selective and potent sigma-1 receptor (S1R) agonist in development… read more here.
Keywords: disease; profile pridopidine; profile; safety profile ... See more keywords